Mandate

Vinge advises Syncron AB in conjunction with the merger with Mize, Inc.

August 18, 2021 M&A

Vinge has advised Syncron in conjunction with the merger with the US company, Mize.

The merged company will be the world’s largest unlisted global actor within the industrial companies’ after-sales service industry. At present, the companies are leading actors in the cloud-based SaaS solutions on their respective markets and will conducts operations under the trademark Syncron. The company’s headquarters will be in Stockholm.

Vinge’s team primarily consisted of Johan WinnerbladMikael StåhlCarl SanderLionardo Ojeda and Isabelle Jengsell.

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026